Scientific Sessions
Friday, October 30, 2026 | 7:00 AM – 6:30 PM
The Ritz-Carlton, Coconut Grove
All Times are EDT
Program is subject to change
| 7:00 – 8:00 | Registration, Exhibits, Posters & Breakfast | |
|---|---|---|
| 8:00 – 8:15 | Welcome Remarks Institute Video |
Center Director & Executive Dean for Research Sylvester Survivorship & Supportive Care Institute Director Sylvester Survivorship & Supportive Care Institute Medical Director |
| Morning Sessions | ||
|---|---|---|
| 8:15 – 9:05 | Psychosocial Interventions and Health-Related Quality of Life |
Accelerated Aging in Breast Cancer
Symptom Burden Management in HSCT
Moderator:
|
| 9:05 – 9:55 | AI and Technology-Enabled Interventions |
Innovations in AI to Manage Cancer Survivorship
AI-Enabled Supportive Care for Survivors
Moderator:
|
| 9:55 - 10:45 | AM Keynote Changing the Face of Survivorship |
University of California, Los Angeles Moderator: |
|||
|---|---|---|---|---|---|
| 10:45 – 11:15 | Morning Break, Exhibits & Trainee Posters | |
|---|---|---|
| 11:15 – 12:05 | Pediatric and AYA Survivorship |
Pediatric and AYA Outcomes Research
Late Effects Management in Cancer Survivorship
Moderator:
|
| 12:05 – 12:55 | Lifestyle Medicine and Survivorship Outcomes |
Modifiable Metabolic Processes and Survivorship
Community Engaged Research Models
Moderator:
|
| 12:55 – 1:55 | Lunch, Networking & Poster Viewing | |
|---|---|---|
| Afternoon Sessions | ||
|---|---|---|
| 1:55 – 2:45 | Innovations in Care Delivery |
Genetic Testing in Cancer Survivors
Precision Management in Prostate Cancer
Moderator:
|
| 2:45 – 3:35 | Precision Care to Optimize Survivorship Outcomes |
Improving Responses and Minimizing Toxicities in B-Cell Lymphoma
Immunotherapies Management and Clinical Outcomes
Moderator:
|
| 3:35 – 4:05 | Afternoon Break, Exhibits & Trainee Poster Viewing | |
|---|---|---|
| 4:05 – 4:55 | PM Keynote Survivorship in Primary Care: Integrating Evidence-Based Approaches |
Keynote Moderator: |
|||
|---|---|---|---|---|---|
| 4:55 – 5:30 | Patient and Community Voices in Survivorship Research Panel |
Tamara Beliard Rodriguez
Chair, Community Advisory Committee (CAC) Advocate/Survivor
Advocate/Survivor
Moderator:
|
| 5:30 – 6:30 | Closing Remarks, Poster Viewing and Reception | |
|---|---|---|
Alvaro Alencar, M.D.
Dr Alencar is an Associate Professor of Clinical Medicine and the Chief Medical Director at University of Miami Sylvester Comprehensive Cancer Center. He is a member of the lymphoma program at Sylvester and the lymphoma committee at the Alliance for Clinical Trials in Oncology with a focus on clinical research of b-cell lymphoid malignancies with special interest in minorities, particularly elderly and Hispanics. His research focus is on the application of novel agents to improve responses and minimize toxicity on the care of elderly patients. Dr Alencar also focuses on improving access to care and defining the impact of social determinants of health on outcomes of patients with lymphoid malignancies. As the hematology section lead for the Sylvester's Global Oncology Program, Dr Alencar serves as an important bridge to the United States for Latin American hematologists through research and clinical collaborations.
Frank J Penedo, Ph.D.
Professor of Psychology and Medicine
Sylvester DCC Living Proof Endowed Chair in Cancer Survivorship
Director, Cancer Survivorship and Supportive Care
Center Associate Director, Population Sciences
Sylvester Comprehensive Cancer Center, Miller School of Medicine
University of Miami
Frank J. Penedo, Ph.D. is the Associate Director for Population Sciences and Associate Director for Cancer Supportive Care and Survivorship at the NCI-designated University of Miami Sylvester Comprehensive Cancer Center He also serves as a Sylvester Professor of Psychology and Medicine. Over the past 24 years, his research has focused on evaluating the role of psychosocial and sociocultural processes in adjustment, health related quality of life (HRQoL) and health outcomes in diverse chronic disease populations including and primarily in cancer. His research program focuses on understanding the roles of sociocultural, biobehavioral, care delivery and psychosocial mechanisms underlying disease activity and health outcomes, and the efficacy of evidence-based psychosocial interventions in promoting optimal chronic disease management and health outcomes. In his role as Director of Cancer Survivorship at Sylvester, he oversees implementation of ACOS-CoC standards of supportive and survivorship care and translational research evaluating the impact of distress screening, symptom monitoring and survivorship care programs within Sylvester and via collaborations with Northwestern Medicine. As prior or current PI of multiple NCI and other NIH studies, he has considerable experience in cancer control and survivorship, measurement and management of symptom burden, the delivery of psychosocial interventions, care delivery and health services research and community-based and -engaged approaches to optimize health outcomes in cancer survivors. He has expertise in adapting, implementing and disseminating evidence-based interventions (in-person, via e/mHealth) and EMR-integrated symptom and needs monitoring, triage and intervention in ambulatory cancer survivors. He is past president of the International Society of Behavioral Medicine and elected Fellow of the Academy of Behavioral Medicine Research and the Society of Behavioral Medicine. Dr. Penedo has over 300 peer-reviewed publications, has served as associate editor of several major journals in his field, and has been a standing member of several NIH study. He is the inaugural recipient of the Sylvester DCC Living Proof Endowed Chair in Cancer Survivorship and was recently elected to the National Advisory Council on Minority Health and Health Disparities. He is the 2023 recipient of the International Society of Behavioral Medicine Distinguished Scientist Award.
Lara Traeger, Ph.D.
Dr. Traeger is a clinical psychologist and an Associate Professor in Psychology at the University of Miami. She serves as Assistant Director of Population Sciences at the UM/Sylvester Comprehensive Cancer Center. Dr. Traeger conducts patient- and family-centered research to enhance quality of life and quality of care among adults affected by cancer. She has collaborated on several national trials of supportive and palliative care interventions for patients and their families, including current trials to improve care for patients facing complex survivorship challenges.
Melissa Lopez-Pentecost, Ph.D.
Dr. Melissa Lopez is a Registered Dietitian and Assistant Professor at the Sylvester Comprehensive Cancer Center within the University of Miami Miller School of Medicine, where she also serves as the Lead for Nutrition in Lifestyle Medicine and Prevention. As a translational scientist, Dr. Lopez integrates clinical, community, and basic science approaches to advance precision lifestyle interventions for cancer prevention and control across the cancer care continuum. Her research leverages interdisciplinary expertise to identify modifiable metabolic and behavioral targets that inform personalized nutrition and lifestyle strategies to improve cancer-related outcomes.
Michael Antoni, Ph.D.
Director, Health Psychology Division, Department of Psychology
Sylvester Professor of Psychology and Psychiatry and Behavioral Sciences
Cooper Fellow, College of Arts & Sciences
Cancer Control, Sylvester Comprehensive Cancer Center
University of Miami and University of Miami School of Medicine
Dr. Antoni is Director of the Health Psychology Division in the Department of Psychology at the University of Miami, Sylvester Professor of Psychology and Psychiatry and Behavioral Sciences at the University of Miami, a College of Arts & Sciences Cooper Fellow, and a member of the Cancer Control program and the Center for AIDS Research (CFAR), and a licensed psychologist in the State of Florida.
He has received extensive continuous extramural support from NIH for 40 years (including P50 and multiple R01s) and published about 800 journal articles, books, book chapters and abstracts on clinical health psychology and biobehavioral medicine topics. These include effects of stress factors, social resources and stress management interventions on psychological adaptation, biological processes, and clinical health outcomes in chronic diseases such as HIV/AIDS, chronic fatigue syndrome, and breast, prostate and cervical neoplasias.
Dr. Antoni lead clinical translational work that has adapted the content, format and delivery of stress management and health behavior change interventions through community based participatory research methods, linguistic and cultural translation, and remote delivery technologies (telephone, eHealth and mobile phone apps [mHealth]) to reach the most underserved cancer populations in South Florida.
He directed federal training grants from the NIH and Department of Defense, mentored multiple faculty K-grant recipients and over 70 doctoral students and post-doctoral fellows in behavioral medicine and health psychology.
Over the past 20+ years Dr. Antoni served as Associate Editor for two interdisciplinary behavioral medicine journals: International Journal of Behavioral Medicine and Psychology and Health. Dr. Antoni is a Society of Behavioral Medicine (SBM) Fellow and previously received Young Investigator Awards from the SBM and the American Psychological Association, the Distinguished Scientist Award from the International Society of Behavioral Medicine, the SCCC Zubrod Lifetime Achievement Award and the Lifetime Achievement Award from SBM's Cancer SIG. He recently served as Associate Editor of the American Psychological Association's Handbook of Health Psychology.
Patricia Moreno, Ph.D.
Dr. Moreno is a licensed clinical psychologist and an Associate Professor of Public Health Sciences at the University of Miami Miller School of Medicine. She is also Lead of Evidence-Based Survivorship and Supportive Care at the Sylvester Comprehensive Cancer Center. The overarching aim of Dr. Moreno's research is to support emotional wellbeing and quality of life among individuals coping with cancer and improve outcomes across the cancer continuum through patient-centered healthcare and tailored, empirically-supported interventions. She has received more than $8 million of grant funding as a Principal Investigator. Dr. Moreno also has experience providing evidence-based care to English- and Spanish-speaking cancer survivors and their family members across three NCI-designated comprehensive cancer centers: UCLA, Duke University, and Northwestern University.
Sara Fleszar-Pavlovic, Ph.D.
Dr. Fleszar-Pavlovic is a Research Assistant Professor in the Department of Medicine, Division of Medical Oncology, at the University of Miami Miller School of Medicine. She also serves as Research Operations Lead for the Survivorship and Supportive Care Institute at Sylvester Comprehensive Cancer Center. Her research examines ways to improve quality of life and patient reported and clinical outcomes across the cancer care continuum. She uses theory driven approaches to design and evaluate supportive care interventions emphasizing culturally relevant and scalable solutions for Hispanic and older adult cancer survivors, addressing challenges linked to survivorship, multimorbidity, and aging related changes in physical and psychosocial well-being. Her most recent efforts involve integrating agentic artificial intelligence (AI) platforms capable of delivering guideline concordant and adaptive supportive care interventions.
Stephen Nimer, M.D.
Director, Sylvester Comprehensive Cancer Center
Oscar de la Renta Endowed Chair in Cancer Research
Executive Dean for Research, Leonard M. Miller School of Medicine
Professor of Medicine, Biochemistry and Molecular Biology, Leonard M. Miller School of Medicine
Dr. Nimer has been studying the transcriptional regulation of normal and malignant hematopoiesis for decades, with the aim of understanding how the normal processes of stem cell self-renewal and differentiation are regulated and how these processes are aberrant in the myeloid malignancies. Overall, his lab has focused on defining genes that contribute to the development and progression of myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML) and on identifying novel ways to target hematologic cancers and make them more responsive to treatment.
As a physician-scientist, Dr. Nimer has cared for patients with MDS, AML, multiple myeloma, and lymphoma for over three decades. This melding of clinical studies and care, with both basic laboratory and translational studies, reflects the fundamental focus of his career.
Since coming to the University of Miami-Miller School of Medicine in 2012 and assuming the Directorship of the Sylvester Comprehensive Cancer Center, the center received the prestigious National Cancer Institute designation in July 2019. Sylvester is the only cancer center in South Florida to achieve this designation and the second in the state of Florida. Dr. Nimer is currently supported by two NCI R01 grants and a Leukemia and Lymphoma Society (LLS) multi-project Specialized Center of Research (SCOR) award. In November 2019, Dr. Nimer was named the inaugural Oscar de la Renta Endowed Chair in Cancer Research. In November 2021, Dr. Nimer assumed the role of Executive Dean for Research for the Miller School of Medicine, and in May 2022, he assumed a secondary appointment as Professor of Chemical, Environmental & Materials Engineering.
Prior to his arrival at the University of Miami-Miller School of Medicine, Dr. Nimer was at Memorial Sloan-Kettering Cancer Center in New York for nearly 20 years, where he held the Alfred P. Sloan Chair and served as Head of the Division of Hematologic Oncology, Vice Chairman for Faculty Development, and Chief of the Hematology Service. He was also a Professor of Medicine and Pharmacology at Weill Medical College of Cornell University. Dr. Nimer has been elected to the American Society of Clinical Investigators and the Association of American Physicians. He is a Fellow of the American College of Physicians and serves on the editorial board of several medical journals. In April 2021, Dr. Nimer was inducted into the Academy of Science, Engineering, and Medicine of Florida. Dr. Nimer is also the Chairman of the Myelodysplastic Syndrome Foundation, and the Chairman of the Medical Advisory Board of Gabrielle's Angel Foundation for Cancer Research.
Tracy Crane, Ph.D.
Dr. Tracy E. Crane is an internationally recognized thought leader in cancer prevention and control, specializing in digital health interventions to improve patient outcomes. She is the recipient of the inaugural Brigette Burke Endowed Chair for Women's Cancer Research and is an Associate Professor of Medical Oncology and Public Health at the Miller School of Medicine, and Kinesiology and Sports Sciences in the School of Human Development and Education at the University of Miami. At Sylvester Comprehensive Cancer Center she Co-Leads the Cancer Control Research Program and is the Director of Lifestyle Medicine, Prevention, and Digital Health. Dr. Crane leads a multidisciplinary research team focused on innovative lifestyle interventions, leveraging AI-driven technology to deliver precision behavioral strategies. In the last 5 years, she has secured over $35 million in research funding, including multiple National Cancer Institute (NCI)-funded studies and a large PCORI-funded trial, and has authored over 115 peer-reviewed publications, including co-authoring the latest American Cancer Society guidelines on nutrition and physical activity for cancer survivors. A Registered Dietitian with a Ph.D. in Nursing Science, Dr. Crane also serves as Chair for Cancer Prevention and Control Nationally for NRG Oncology's NCI Community Oncology Research Program. Her pioneering contributions have made her a sought-after speaker and leader in the global effort to integrate digital health and personalized lifestyle medicine into cancer prevention and care.
Carmen Calfa, MD
Associate Professor of Clinical Medicine
Breast Medical Oncologist
Clinical Research Lead, Breast Site Disease Group
Physician Leader, Genetic Predisposition Syndrome (GPS) Program
Associate Director of Community Outreach–Breast Cancer Program–Plantation
Medical Director, Cancer Survivorship and Supportive Care Institute
Sylvester Comprehensive Cancer Center
Miller School of Medicine | University of Miami
Dr. Calfa is an Associate Professor of Clinical Medicine at the University of Miami Miller School of Medicine, Associate Director of Community Outreach and Medical Co-Director of the Survivorship Cancer Program at Sylvester Comprehensive Cancer Center.
She also serves as the Clinical Research Lead for the Breast Site Disease Group and Physician Leader of the Genetic Predisposition Syndrome Initiative at Sylvester Comprehensive Cancer Center. Furthermore, she leads Sylvester's Multidisciplinary Survivorship Clinic Program and plays a key role in the Adolescent and Young Adult Steering Committee.
Carmen Calfa, M.D., dedicates her efforts to increasing cancer survival through access to innovative research and improving the quality of life for survivors and their caregivers.
Dr. Calfa is the recipient of the Zubrod 2020 Outstanding Clinical Researcher of the Year Award and the 2020 Miami Dolphins Everyday Hero Award.
She is the institutional principal investigator for several clinical trials, and she leads the Precision Medicine Clinical Trials Initiative at Sylvester. Dr. Calfa serves as the institutional principal investigator and co-investigator for multiple clinical trials in the breast cancer treatment and survivorship space. She leads the precision medicine clinical trials at Sylvester including the I-SPY trial as well as ASCO's TAPUR Study and has served as the chair of TAPUR's steering committee. She is looking forward to continuing her work with the ASCO-TAPUR team and expanding precision medicine options to patients everywhere.
She earned a medical degree from the University of Medicine and Pharmacy of Tirgu-Mures in Romania and has completed Internal Medicine Residency as well as Hematology-Oncology Fellowship training at Jackson Memorial Hospital/ University of Miami, Miller School of Medicine.
Vasileios Stathias, PhD
Vasileios Stathias, Ph.D., serves as the Assistant Director for Data Science at the Sylvester Comprehensive Cancer Center and the Lead Data Scientist in the Department of Molecular and Cellular Pharmacology at the University of Miami. He oversees the development of the Sylvester Data Portal, a comprehensive multi-omics data platform supporting the FAIR management, automated processing, and intuitive analysis of high-throughput research and Real-World data generated at Sylvester. Dr. Stathias' research leverages AI and bioinformatics to develop novel precision medicine approaches, and he has led multiple high-impact projects in national cancer research consortia, including NIH LINCS, NCI CPTAC, and AACR GENIE. Dr. Stathias earned his B.Sc. in Molecular Biology and Genetics from the Democritus University of Thrace and completed his Ph.D. in Human Genetics and Genomics at the University of Miami.
Akina Natori, MD, MSPH
Akina Natori, MD, MSPH, is a Research Assistant Professor in the Division of Medical Oncology at the University of Miami and Sylvester Comprehensive Cancer Center. Her research focuses on cancer survivorship, with an emphasis on patient-reported outcomes, symptom monitoring, and supportive care interventions. She has extensive experience working with electronic health record and real-world clinical data, applying advanced statistical and analytic methods to improve survivorship care. Dr. Natori is particularly interested in developing and evaluating technology-enabled and digital health interventions to enhance symptom management, quality of life, and healthcare delivery for cancer survivors. Her current work includes web-based behavioral interventions and data-driven approaches that leverage emerging technologies to address unmet survivorship needs. She collaborates across multidisciplinary teams to translate research findings into clinically meaningful applications.
Raymond Mailhot, MD
Director, University of Miami Pediatric Radiotherapy Program
Medical Director, Dwoskin Proton Therapy Center
Physician Lead, Adolescent Young Adult Cancer Survivorship Program
Dr. Mailhot serves as Director of the University of Miami Pediatric Radiotherapy Program, Medical Director of the Dwoskin Proton Therapy Center, and Physician Lead of the Adolescent Young Adult Cancer Survivorship Program for the Sylvester Comprehensive Cancer Center. His current NCI and Leukemia & Lymphoma Society–funded projects focus on improving outcomes among Hodgkin lymphoma survivors from communities in need. His research was the first in the United States to establish a direct linkage between patients' electronic medical records and their public school data—sources protected respectively by HIPAA and FERPA. This groundbreaking integration allowed for understanding how cancer and its treatments affect not only survival, but also academic and social reintegration for children and adolescents. They were the first group worldwide to identify and report correlations between radiation dose to critical brain regions and subsequent school performance. This work was funded by the Florida Department of Health.
Meghan McCormick, MD, MS
Meghan McCormick, MD MS is an Assistant Professor in the Division of Pediatric Hematology/Oncology in the Department of Pediatrics at the University of Miami Miller School of Medicine. Dr. McCormick's research focuses on improving supportive care practices through cost-effectiveness modelling, administrative databases research and quality improvement studies. Dr. McCormick's clinical work is focused on the development of a multidisciplinary pediatric survivorship and late effects clinic at the Sylvester Comprehensive Cancer Center.
Prior to joining UM, Dr. McCormick completed residency and fellowship training at the University of Pittsburgh Medical Center. She received a master of clinical research with a focus in clinical trial development from the University of Pittsburgh.
Aditi Dhir, M.D.
Director, Pediatric Cancer Predisposition Clinic, University of Miami
As a pediatric hematologist-oncologist, Dr. Dhir treats children, adolescents and young adults with sarcomas, as well as those with genetic cancer predispositions. Her research focuses on identifying cancer in its earliest stages and utilizing precision medicine and immunotherapy to provide better outcomes.
Dr. Aditi Dhir joined Sylvester Comprehensive Cancer Center and the University of Miami Miller School Department of Pediatrics as a clinical assistant professor in the Division of Pediatric Hematology/Oncology in 2020. She earned her medical degree from Lady Hardinge Medical College in New Delhi, India, in 2013. She continued her training with a pediatric residency at Cleveland Clinic Children's Hospital in Ohio, followed by a pediatric hematology and oncology fellowship at Children's of Alabama at the University of Alabama at Birmingham, completed in 2020.
Dr. Dhir is the director of the Pediatric Cancer Predisposition Clinic at the University of Miami which aims to identify children with an inherited risk of cancer to allow for early implementation of surveillance measures. She is also the site principal investigator (PI) for pediatric phase I research studies through the Sunshine Project (National Pediatric Cancer Foundation) and the Children's oncology group (COG). In addition, Dr. Dhir is involved in numerous research projects, including therapeutic and non-therapeutic clinical trials for children and young adults with various histological subtypes of sarcomas and other cancer types.
She has received numerous accolades for her work including the V Foundation Early Career Investigator Award, Micah Batchelor Scholar Awards for Excellence in Children's Health Research and more recently was honored with the Sebastian Strong Dolphins Cancer Challenge endowed chair in Pediatric Cancer research.
Paola Rossi, MD
Dr. Paola Rossi is an Argentine-born family and palliative care physician with a master's in exercise and nutrition and certification in culinary medicine. She is a leader in lifestyle medicine and oncology at Sylvester Comprehensive Cancer Center in South Florida. Her work focuses on integrating evidence-based nutrition, physical activity, and behavior change strategies to improve outcomes for cancer survivors and individuals at high risk. She has developed and led innovative programs, including large-scale community initiatives reaching over 100 participants, and has contributed to research, education, and clinical care in the field.
Nicholas Borja, MD
Assistant Professor of Clinical Genetics, University of Miami Miller School of Medicine
Dr. Nicholas Borja is a board-certified medical geneticist and Assistant Professor of Clinical Genetics at the University of Miami Miller School of Medicine with a research focus on hereditary cancer predisposition. He has authored studies analyzing genetic and environmental factors in patients with multiple primary malignancies and described new phenotypes associated with Gorlin syndrome and ATM-related cancer susceptibility. In 2025, he received grant funding from the American Cancer Society to work towards discovering novel genetic causes of cancer risk. In addition, as co-investigator with the University of Miami's Undiagnosed Diseases Network clinical site, he has helped characterize ultra-rare genetic disorders in pediatric and adult patients.
Sanoj Punnen, MD
Professor and Vice Chair of Clinical Research, Desai Sethi Urology Institute
Dr. Sanoj Punnen is a Professor and Vice Chair of Clinical Research in the Desai Sethi Urology Institute at the University of Miami Miller School of Medicine and Sylvester Cancer Center. He is a fellowship trained uro-oncologist with a masters in clinical research who is focused on prostate cancer and clinical trials. He has over 500 patients on NCI funded clinical trials and has published over 150 manuscripts on prostate cancer, in addition to being a past editor for the Journal of Urology. Dr. Punnen serves as Co leader of the Cancer Control Research Program and Assistant Director of Clinical Research at Sylvester Cancer Center and is the proud recipient of the Pap Corps Champions for Cancer Research Endowed Chair in Solid Tumor Research.
Matthew Schlumbrecht, MD
Professor, Division of Gynecologic Oncology, Sylvester Comprehensive Cancer Center
Dr. Schlumbrecht is a Professor in the Division of Gynecologic Oncology at the Sylvester Comprehensive Cancer Center in Miami, Florida. He serves as the Assistant Director of Community Outreach and Engagement; Medical Co-Director for Education and Training, Sylvester Cancer Survivorship Institute; and Translational Co-lead for the Gynecologic Oncology Site Disease Group. He also serves as the Vice Chair of Global and Community Health in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of Miami Miller School of Medicine. In this capacity he acts as the international mentor for five international gynecologic oncology fellows in Nigeria and Bahamas through the International Gynecologic Cancer Society, for which he is the co-chair for the International Mentor and Local Supervisor Resource Committee.
A graduate of The University of Texas Medical School at Houston, Dr. Schlumbrecht completed an OB/GYN residency at The University of Texas-Southwestern Medical Center in Dallas and a Gynecologic Oncology fellowship at The University of Texas MD Anderson Cancer Center in Houston. He holds a Master of Public Health in Epidemiology from the University of Texas. His clinical care of patients is complemented by his ongoing research in translational science and global health, with a specific interest in cancer prevention and education, early detection, and novel therapeutics. He works closely with global partners to facilitate comprehensive research in endometrial and hereditary cancers, as well as expansion of clinical trials to populations in need.
He is the recipient of the 2025 University of Miami Provost Award for Outstanding Clinical Teaching. He has published in numerous peer-reviewed journals, including the Journal of Clinical Oncology, the American Journal of Obstetrics & Gynecologic, Cancer, and Gynecologic Oncology.
Jose Lutzky, MD
Director of Cutaneous Oncology
Cutaneous and Ocular Oncology Site Disease Group Lead
Medical Director, Clinical Trials Coordination Office
Dr. Jose Lutzky is Director of Cutaneous Oncology, Cutaneous and Ocular Oncology Site Disease Group Lead and Medical Director of the Clinical Trials Coordination Office at the University of Miami Sylvester Comprehensive Cancer Center in Miami, Florida. Dr. Lutzky graduated from Universidade Federal do Rio Grande do Sul Medical School, Brazil in 1980, completed his residency in Internal Medicine at Mount Sinai Medical Center in Miami and a Fellowship in Hematology/Oncology at Columbia University in New York. He joined the faculty of University of California, Irvine in 1988 and moved to Florida in 1994. His main interest is in clinical and translational research in cutaneous malignancies and uveal melanoma.
Patricia A. Ganz, MD
Patricia A. Ganz, MD, is Distinguished Professor of Medicine at the David Geffen School of Medicine at UCLA and Distinguished Professor of Health Policy & Management, at the UCLA Jonathan and Karin Fielding School of Public Health as well as the Associate Director for Population Science Research, at the UCLA Jonsson Comprehensive Cancer Center in Los Angeles, California. Dr. Ganz is a Fellow of ASCO and Fellow of AACR and is an elected member of the National Academy of Medicine and the Association of American Physicians.
Dr. Ganz is a medical oncologist and a founding member of the National Coalition for Cancer Survivorship in 1986. She is a pioneer in the assessment of quality of life in cancer patients and has focused much of her clinical and research efforts in the areas of breast cancer and its prevention. Her major areas of research include cancer survivorship, understanding the late effects of cancer treatment, measurement of patient reported outcomes in clinical treatment trials, and quality of care for cancer patients.
She has been engaged with NSABP/NRG Oncology for more than 30 years, leading various quality of life and outcomes studies starting with the breast cancer prevention trials in the 1990s and many treatment trials during the past two decades. Currently, she is co-leading NRG Oncology CC015 that is focused on testing three digital delivery strategies for training in mindfulness meditation in younger breast cancer survivors with increased depressive symptoms.
Adrienne Vazquez Guerra, MSN, ARPN, ACNP-BC, AOCNP®
Mrs. Adrienne Vazquez Guerra is a board-certified acute care nurse practitioner. Mrs. Vazquez Guerra has worked in various roles within oncology which include inpatient and outpatient general oncology/hematology, thoracic oncology, outpatient infusion center, clinical trials, survivorship and management of several clinical programs. Mrs. Vazquez Guerra is an Advanced Oncology Certified Nurse Practitioner® (AOCNP) and is a past ONCC national chair for the item writing and test development national committees for the AOCNP board exam. She is a past president of the Miami-Dade chapter of the Oncology Nursing Society. Her current role at Sylvester Comprehensive Cancer Center is nurse practitioner and clinical operations within the Cancer Survivorship program.
Tamara Beliard Rodriguez
Chair, Community Advisory Committee (CAC)
Full bio coming soon.
Jessica MacIntyre, DNP, MBA, APRN, AOCNP
Executive Director, Clinical Operations
Director, Oncology Nurse Practitioner Fellowship Program
Sylvester Comprehensive Cancer Center
University of Miami Miller School of Medicine
Miami, FL
Dr. Jessica MacIntyre is the Executive Director of Clinical Operations and an Advanced Registered Nurse Practitioner at the University of Miami/Sylvester Comprehensive Cancer Center. Dr. MacIntyre received her Doctor in Nursing Practice and MBA from Johns Hopkins University. She has been practicing for over 20 years in the field of oncology and currently oversees the clinical operations of various department and programs at the cancer center including, cancer support services, cancer prevention programs, cancer survivorship, the phase I research clinic, and the advanced practice providers involved in these areas. Additionally, she has publications in the areas of gastrointestinal malignances, advanced practice, and is an avid speaker on topics revolving around patient navigation, survivorship, and supportive care. She is also the co-founder and the Director of the Oncology Nurse Practitioner Fellowship Program and University of Miami; the first and only one in Florida.
Have Questions?
Please contact SurvivorshipSymposium@miami.edu for any survivorship symposium related questions.
To learn more about our Survivorship Research and Clinical Programs please visit Sylvester Survivorship and Supportive Care Institute.